NL-OMON31925尚未招募4 期
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosing - ASSIG
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age > 18 years
- •Diagnosis of type 2 diabetes according to ADA criteria
排除标准
- •Current acetylsalicylic acid therapy
- •Use of any medication interfering with platelet function, e.g. diclofenac, naproxen or clopidogrel
- •Allergy or hypersensitivity to prostaglandinsynthetase inhibitors
- •Hemorrhagic stroke in medical history
- •Gastric complaints or gastritis/ulcus pepticum
- •Severe liver or kidneyfailure
研究者
相似试验
进行中（未招募）
不适用
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosing - ASSIGType 2 diabetesMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-001308-22-NLAcademic Medical Centre
尚未招募
不适用
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosingNL-OMON26330Prof. dr. J.B.L. HoekstraDept. of Internal MedicineAcademic Medical Centre140
已完成
不适用
Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic PatientsDiabetes Mellitus, Type IINCT00649909Hadassah Medical Organization18
Unknown
4 期
Aspirin Resistance Reversibility in Diabetic PatientsAspirin ResistanceNCT01935193Azienda Ospedaliera San Giovanni Battista160
已完成
4 期
Aspirin Dosing in Diabetic PatientsType 2 Diabetes MellitusCoronary Artery DiseaseNCT01201785University of Florida20